27-Oct-2026 10:09:04

ONESOURCE SPECIALTY PHARMA Q2 FY27 (CONS.) ; NET PROFIT UP 448.25% AT ₹57.48 CR (YOY), UP 129.96% (QOQ)

REVENUE UP 37.39% AT ₹516.24 CR (YOY), UP 14.97% (QOQ) EBITDA UP 53.33% AT ₹163.29 CR (YOY), UP 32.38% (QOQ) MARGINS AT 31.63% VS 28.34% (YOY), 27.47% (QOQ)

ONESOURCE SPECL PHARMA L

← Back to feed